Turning Point Therapeutics, Inc. TPTX
75.49 0.00 (+0.00%)
At closeAug 15, 2022, 4:00 PM EDT
75.30 Day range 75.77
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 71.50 -5.3% downside
Now 75.49
- Target (low)
- 58.00
- Target (mean)
- 71.50
- Target (high)
- 76.00
Ratings (-1m) 9 1 buy · 8 hold · 0 sell
- Strong buy1
- Buy0
- Hold8
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 9
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -1.34 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -1.58 | 0.0% | 8.33M | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 25.50M | -17.3% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 34.87M | +36.7% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 13, 2022 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Jun 6, 2022 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Jun 6, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Jun 3, 2022 | Wedbush | Downgrade | Outperform | Neutral |
| May 24, 2022 | Goldman Sachs | Maintained | — | Buy |
| May 20, 2022 | B of A Securities | Initiated | — | Buy |
| May 11, 2022 | SVB Leerink | Maintained | — | Outperform |
| Mar 22, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 1, 2022 | Stifel | Maintained | — | Hold |
| Feb 10, 2022 | Wells Fargo | Maintained | — | Overweight |
| Jan 21, 2022 | Oppenheimer | Maintained | — | Outperform |
| Dec 7, 2021 | Cowen & Co. | Initiated | — | Outperform |
| Nov 10, 2021 | Oppenheimer | Maintained | — | Outperform |
| Oct 12, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 11, 2021 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Sep 30, 2021 | Stifel | Initiated | — | Hold |
| Apr 6, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 2, 2021 | Canaccord Genuity | Maintained | — | Buy |
| Jan 19, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 14, 2020 | SVB Leerink | Maintained | — | Outperform |
| Dec 8, 2020 | JMP Securities | Initiated | — | Market Outperform |
| Oct 27, 2020 | Canaccord Genuity | Maintained | — | Buy |
| Oct 26, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 26, 2020 | SVB Leerink | Maintained | — | Outperform |
| Sep 21, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 21, 2020 | Canaccord Genuity | Maintained | — | Buy |
| Jul 10, 2020 | Oppenheimer | Initiated | — | Outperform |
| May 26, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| May 13, 2020 | Wells Fargo | Maintained | — | Overweight |
| May 13, 2020 | SVB Leerink | Maintained | — | Outperform |